Susan Kelly

6 days ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. The Securities and Exchange Commission has concluded its investigation into Illumina’s 2021 acquisition of liquid biopsy maker Grail and recommended no enforcement action be taken, the company said Thursday. Illumina spun off Grail in 2024, following several tumultuous years in which regulators had challenged the $8 billion takeover, ultimately forcing the separation.

1 week ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. Jeremy Walsh will lead the Food and Drug Administration’s artificial intelligence efforts as chief AI officer, the agency confirmed Thursday. The appointment comes as the FDA launches the rollout of a generative AI platform across its centers, according to the statement.

1 week ago | finance.yahoo.com | Susan Kelly

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Jeremy Walsh will lead the Food and Drug Administration’s artificial intelligence efforts as chief AI officer, the agency confirmed Thursday. The appointment comes as the FDA launches the rollout of a generative AI platform across its centers, according to the statement.

1 week ago | manufacturingdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. The U.S. Commerce Department’s Section 232 investigation into semiconductor imports could create substantial new costs for the medtech sector if it brings additional tariffs, especially for medical devices that are chip-intensive or produced at a large scale, according to experts who spoke with MedTech Dive. President Donald Trump’s tariffs are already causing financial fallout for device makers.

1 week ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. Masimo said Tuesday it agreed to sell its Sound United consumer audio portfolio for $350 million to Samsung Electronics’ Harman International unit, freeing the company to focus on its professional healthcare business. The sale is expected to close by the end of 2025, subject to regulatory approvals.